Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer

Find Full text
Publication year
2021
Author(s)
Vrede, S.W.
Weelden, W.J. van
Visser, N.C.M.
Bulten, J.
Putten, L.J.M. van der
Vijver, Koen van de
Reijnen, C.
Pijnenborg, J.M.A.
Source
Gynecologic Oncology, 161, 3, (2021), pp. 787-794
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/234186   https://hdl.handle.net/2066/234186
Display more details

Upload full text

Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.